Workflow
Overview
CaseMark's Informed Consent Form skill uses AI to draft comprehensive, IRB-ready consent documents for FDA-regulated clinical trials. It automatically structures all required elements under 21 CFR 50.25, ICH-GCP, and HIPAA into a plain-language document that research subjects can clearly understand. From protocol extraction to risk tables and signature blocks, the entire ICF is generated in minutes.
Drafting Informed Consent Forms for clinical trials is one of the most time-consuming regulatory tasks in clinical research. Each ICF must address dozens of required elements across FDA regulations, ICH-GCP guidelines, and HIPAA requirements—all written in plain language that research subjects can understand. Manual drafting often takes days, involves multiple revision cycles, and risks omitting critical regulatory elements.
CaseMark automates the heavy lifting of ICF creation by extracting study design, risk profiles, and procedural details directly from your protocol and investigator brochure. The AI assembles a complete, regulation-compliant consent document with structured visit tables, categorized risk disclosures, HIPAA authorization, and signature blocks—all at a plain-language reading level ready for IRB review.